6.
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211.
DOI: 10.1177/0333102417738202.
View
7.
Cicilet S, Reddy K S, Kancharla M
. Insights into neurosarcoidosis: an imaging perspective. Pol J Radiol. 2024; 88:e582-e588.
PMC: 10867949.
DOI: 10.5114/pjr.2023.134021.
View
8.
Voortman M, Hendriks C, Elfferich M, Bonella F, Moller J, de Vries J
. The Burden of Sarcoidosis Symptoms from a Patient Perspective. Lung. 2019; 197(2):155-161.
PMC: 6486948.
DOI: 10.1007/s00408-019-00206-7.
View
9.
Bast A, Semen K, Drent M
. Nutrition and corticosteroids in the treatment of sarcoidosis. Curr Opin Pulm Med. 2018; 24(5):479-486.
DOI: 10.1097/MCP.0000000000000501.
View
10.
Byg K, Illes Z, Sejbaek T, Nguyen N, Moller S, Lambertsen K
. A prospective, one-year follow-up study of patients newly diagnosed with neurosarcoidosis. J Neuroimmunol. 2022; 369:577913.
DOI: 10.1016/j.jneuroim.2022.577913.
View
11.
Graves J, Nunley K, Heffernan M
. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol. 2006; 56(1):e55-79.
DOI: 10.1016/j.jaad.2006.07.019.
View
12.
Durel C, Marignier R, Maucort-Boulch D, Iwaz J, Berthoux E, Ruivard M
. Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients. J Neurol. 2016; 263(5):981-990.
DOI: 10.1007/s00415-016-8092-5.
View
13.
Nozaki K, Scott T, Sohn M, Judson M
. Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist. 2012; 18(6):373-7.
DOI: 10.1097/NRL.0b013e3182704d04.
View
14.
Zajicek J, Scolding N, Foster O, Rovaris M, Evanson J, Moseley I
. Central nervous system sarcoidosis--diagnosis and management. QJM. 1999; 92(2):103-17.
DOI: 10.1093/qjmed/92.2.103.
View
15.
Chang B, Steimel J, Moller D, Baughman R, Judson M, Yeager Jr H
. Depression in sarcoidosis. Am J Respir Crit Care Med. 2001; 163(2):329-34.
DOI: 10.1164/ajrccm.163.2.2004177.
View
16.
Sharp M, Brown T, Chen E, Rand C, Moller D, Eakin M
. Psychological burden associated with worse clinical outcomes in sarcoidosis. BMJ Open Respir Res. 2019; 6(1):e000467.
PMC: 6797341.
DOI: 10.1136/bmjresp-2019-000467.
View
17.
Rossides M, Darlington P, Kullberg S, Arkema E
. Sarcoidosis: Epidemiology and clinical insights. J Intern Med. 2023; 293(6):668-680.
DOI: 10.1111/joim.13629.
View
18.
Ireland J, Wilsher M
. Perceptions and beliefs in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010; 27(1):36-42.
View
19.
Kettenbach S, Radke S, Muller T, Habel U, Dreher M
. Neuropsychobiological Fingerprints of Chronic Fatigue in Sarcoidosis. Front Behav Neurosci. 2021; 15:633005.
PMC: 8350031.
DOI: 10.3389/fnbeh.2021.633005.
View
20.
Hoitsma E, Faber C, Drent M, Sharma O
. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004; 3(7):397-407.
DOI: 10.1016/S1474-4422(04)00805-1.
View